These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 38395061)

  • 1. GAS6/TAM Axis as Therapeutic Target in Liver Diseases.
    Tutusaus A; Morales A; García de Frutos P; Marí M
    Semin Liver Dis; 2024 Feb; 44(1):99-114. PubMed ID: 38395061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
    Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the vitamin K-dependent proteins GAS6 and protein S and the TAM receptor tyrosine kinases in human atherosclerotic carotid plaques.
    Hurtado B; Muñoz X; Recarte-Pelz P; García N; Luque A; Krupinski J; Sala N; García de Frutos P
    Thromb Haemost; 2011 May; 105(5):873-82. PubMed ID: 21384080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment.
    Myers KV; Amend SR; Pienta KJ
    Mol Cancer; 2019 May; 18(1):94. PubMed ID: 31088471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis.
    Smirne C; Rigamonti C; De Benedittis C; Sainaghi PP; Bellan M; Burlone ME; Castello LM; Avanzi GC
    Dis Markers; 2019; 2019():2304931. PubMed ID: 31583026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation.
    Zhou J; Yang A; Wang Y; Chen F; Zhao Z; Davra V; Suzuki-Inoue K; Ozaki Y; Birge RB; Lu Q; Wu Y
    Cell Commun Signal; 2018 Dec; 16(1):98. PubMed ID: 30541554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of TAM family receptors and ligands in the nervous system: From development to pathobiology.
    Shafit-Zagardo B; Gruber RC; DuBois JC
    Pharmacol Ther; 2018 Aug; 188():97-117. PubMed ID: 29514053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression.
    Kasikara C; Kumar S; Kimani S; Tsou WI; Geng K; Davra V; Sriram G; Devoe C; Nguyen KN; Antes A; Krantz A; Rymarczyk G; Wilczynski A; Empig C; Freimark B; Gray M; Schlunegger K; Hutchins J; Kotenko SV; Birge RB
    Mol Cancer Res; 2017 Jun; 15(6):753-764. PubMed ID: 28184013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH.
    Grøndal SM; Tutusaus A; Boix L; Reig M; Blø M; Hodneland L; Gausdal G; Jackson A; Garcia de Frutos P; Lorens JB; Morales A; Marí M
    Front Immunol; 2024; 15():1400553. PubMed ID: 38817615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation.
    Tsou WI; Nguyen KQ; Calarese DA; Garforth SJ; Antes AL; Smirnov SV; Almo SC; Birge RB; Kotenko SV
    J Biol Chem; 2014 Sep; 289(37):25750-63. PubMed ID: 25074926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.
    Lew ED; Oh J; Burrola PG; Lax I; Zagórska A; Través PG; Schlessinger J; Lemke G
    Elife; 2014 Sep; 3():. PubMed ID: 25265470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity.
    Kimani SG; Kumar S; Bansal N; Singh K; Kholodovych V; Comollo T; Peng Y; Kotenko SV; Sarafianos SG; Bertino JR; Welsh WJ; Birge RB
    Sci Rep; 2017 Mar; 7():43908. PubMed ID: 28272423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis.
    Pagani S; Bellan M; Mauro D; Castello LM; Avanzi GC; Lewis MJ; Sainaghi PP; Pitzalis C; Nerviani A
    Dis Markers; 2020; 2020():1614627. PubMed ID: 32051695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis.
    Gao L; He C; Yang A; Zhou H; Lu Q; Birge RB; Wu Y
    Cell Commun Signal; 2023 Aug; 21(1):195. PubMed ID: 37537628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AXL Expression on Homeostatic Resident Liver Macrophages Is Reduced in Cirrhosis Following GAS6 Production by Hepatic Stellate Cells.
    Pop OT; Geng A; Flint E; Singanayagam A; Ercan C; Possamai L; Patel VC; Kuenzler P; Meier MA; Soysal S; Hruz P; Kollmar O; Tatham KC; Ward JK; Müllhaupt B; Weber A; Wendon J; Niess JH; Heim M; Semela D; Weston C; Antoniades CG; Terracciano LM; Triantafyllou E; Brenig RG; Bernsmeier C
    Cell Mol Gastroenterol Hepatol; 2023; 16(1):17-37. PubMed ID: 37004869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAM receptors in phagocytosis: Beyond the mere internalization of particles.
    Burstyn-Cohen T; Fresia R
    Immunol Rev; 2023 Oct; 319(1):7-26. PubMed ID: 37596991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy induced by AXL receptor tyrosine kinase alleviates acute liver injury via inhibition of NLRP3 inflammasome activation in mice.
    Han J; Bae J; Choi CY; Choi SP; Kang HS; Jo EK; Park J; Lee YS; Moon HS; Park CG; Lee MS; Chun T
    Autophagy; 2016 Dec; 12(12):2326-2343. PubMed ID: 27780404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders.
    Gadiyar V; Patel G; Chen J; Vigil D; Ji N; Campbell V; Sharma K; Shi Y; Weiss MM; Birge RB; Davra V
    Front Immunol; 2023; 14():1135373. PubMed ID: 37545504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAM receptors and their ligand-mediated activation: Role in atherosclerosis.
    Cai B; Kasikara C
    Int Rev Cell Mol Biol; 2020; 357():21-33. PubMed ID: 33234243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma.
    Holtzhausen A; Harris W; Ubil E; Hunter DM; Zhao J; Zhang Y; Zhang D; Liu Q; Wang X; Graham DK; Frye SV; Earp HS
    Cancer Immunol Res; 2019 Oct; 7(10):1672-1686. PubMed ID: 31451482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.